Featured
Last news
Fire at Rio de Janeiro carnival costume factory injures 21
A fire broke out Wednesday at a factory making costumes for Rio de Janeiro's carnival, injuring 21 people in a blow to the famed extravaganza starting this month in the Brazilian city.
The US citizens held in Russian prisons
American Marc Fogel is back on US soil Wednesday after being released from a Russian prison, in what US President Donald Trump said he hoped was the start of warming ties between Washington and Moscow.
UN says former Bangladesh govt behind possible 'crimes against humanity'
Bangladesh's former government was behind systematic attacks and killings of protesters as it tried to hold onto power last year, the UN said Wednesday, warning the abuses could amount to "crimes against humanity".
Truck cabin found in Japan sinkhole search for driver
A truck cabin swallowed by a sinkhole in Japan has been found in a sewer pipe and may contain the body of its missing driver, a fire department official said Wednesday.
India's Hindu mega-festival supercharges economy
The unfathomable scale of the world's largest religious festival in India overshadows many nations in size -- and for the economy, its impact is just as dramatic.
After Patagonia, Argentina's northern prairies consumed by fires
Wildfires have consumed up to 250,000 hectares of land in northeast Argentina since January, local officials said Tuesday as firefighters continue to battle blazes in the remote southern region of Patagonia.
Theralase(R) Demonstrates Effective Treatment of Herpes
Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model.
Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results
Net income of $0.8 millionAdjusted EBITDA1 of $1.3 millionPediatric Portfolio net revenue up 86% sequentiallyFirst quarterly sequential prescription increase for both ADHD and Pediatric portfolios since Q2 fiscal 2023$20.4 million cash balance at December 31, 2024Company to host conference call and webcast today, February 12, 2025, at 4:30 p.m. Eastern time
New to the Street Announces 12-Month Partnership With ROADZEN - Monthly Fox Business & Bloomberg Coverage, Earned Media, TV Commercials, and Times Square Billboards
In addition to long-form coverage, New to The Street will also be producing and broadcasting Roadzen commercials on CNBC and FOX Business Network during market hours, as well as across Bloomberg Television and FOX Business during its sponsored programming. This multi-platform strategy will deliver unparalleled exposure for Roadzen's AI-driven auto insurance solutions.
Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025
Investor Call and Webcast Scheduled for 4:30 P.M ET
TPT Global Tech Announces SEC Filing Compliance and Reaffirms Commitment to Shareholders
SAN DIEGO, CA / ACCESS Newswire / February 12, 2025 / TPT Global Tech, Inc. (OTC PINK:TPTW) today announced that it is now fully compliant with all Securities and Exchange Commission (SEC) filing requirements. This achievement reflects the company's commitment to transparency, financial integrity, and delivering long-term value to its shareholders.
The International Roofing Expo Returns to San Antonio with Fresh Content and Expanded Exhibit Space, Energizing the Roofing and Exteriors Community
IRE is the industry's annual hub for products, equipment, hands-on education and networking.
Interactive Strength Inc. (Nasdaq:TRNR) CEO Confirms Sportstech Acquisition and Shares Future Acquisition Strategy at Connected: Health & Fitness Summit
Trent Ward, Ali Ahmad and Mohammed Iqbal Unpack Tailwinds and Major Opportunities in Fragmented Health & Wellness Market During Fireside ChatCompany Also Provides Shareholder Update
Dolphin Leads Major Brand Activations During Super Bowl LVIII
Observer's 2025 #1 Agency of the Year Showcases its Award-Winning Marketing Prowess Across Advertising, Live Events, and Social Media
Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status
The FDA's Fast Track designation is designed to facilitate the development and expedite the review of drugs to treat serious conditions where there is an unmet medical need. FAP, an inherited condition that puts people at a much greater risk of developing colon cancer, falls into that category. The condition is typically diagnosed in the early teenage years and results in a nearly 100% lifetime risk of colorectal cancer.
CTT Pharma Gives Update On NSF Grant
TAMPA, FL / ACCESS Newswire / February 12, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) submitted a full proposal to the National Science Foundation(NSF) for our patented fast dissolving nicotine strips. The NSF grant program is highly competitive as it receives over 12,000 applicants annually from companies that have innovations that could help society. CTT successfully made it past the first round process and is among a few thousand remaining applicants. These remaining applicants have several deadlines over the course of the year to file a full proposal into the grant program. CTT is anticipating an answer in this program in late April. Acceptance into this program would give government backing to CTT Pharma and would allow for extensive research and testing to help lead to development of our technology.
Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters
Relocation to More Efficient Space Supports Growth While Reducing Overhead by Over $200,000 Annually
Dozens evacuated as fire breaks out in 50-floor building in Buenos Aires
Dozens of people were evacuated as a fire broke out in a 50-story Buenos Aires apartment building Tuesday without claiming any lives, emergency services personnel in the Argentine capital said.
Rushdie tells trial of 'lake of blood' after stabbing
Novelist Salman Rushdie described Tuesday the moment a knife-wielding attacker stormed on stage and attempted to kill him with a frenzied attack that left him blind in one eye.
US funding freeze is 'bombshell' for world aid sector
US President Donald Trump's order to suspend most foreign aid has sent shock waves through the humanitarian sector, threatening to trigger mass layoffs at many NGOs and possibly destroy others altogether.
Malaysia's Hindus mark Thaipusam festival with fervour
Hundreds of thousands of Hindus flocked to temples across Malaysia to celebrate the Thaipusam festival Tuesday, with many piercing their bodies with hooks and skewers in acts of devotion.
Philippine divorce activists vow to fight on
In her bid to convince lawmakers to legalise divorce, Filipina fruit vendor Avelina Anuran has publicly testified about the abuse she said she regularly endured at the hands of her husband.
Early Detection Of Breast Cancer Seen As A Benefit With Seated Option in the VELA Mammography Chair, Enable Me Finds in Technologist Survey
"The handicapped and the elderly can be put at ease, and better images obtained with the use of this chair. I would highly recommend every facility that performs mammograms have one of these available for use with their patients."
AI Takes Center Stage at NAB Show with New FBRC.ai Partnership
Discover AI innovation, Trends and Challenges Across the Industry
vVARDIS Announces $35 Million Financing with Global Healthcare Investor OrbiMed to Roll Out Curodont, an Innovative Drill-Free Treatment for Early Tooth Decay
ZUG, SWITZERLAND / ACCESS Newswire / February 11, 2025 / vVARDIS, a Swiss high growth dental company, and OrbiMed, a leading healthcare investment firm, today announced the closing of a $35 million financing. The capital will support the company's growth initiatives and global commercial expansion. vVARDIS is a developer and manufacturer of unique dental products under the Curodont brand, including their innovative drill-free treatment for early tooth decay. Today tooth decay remains number one disease in the world according to the World Health Organization. Last year's rapid expansion of sales, with an initial focus on the U.S., already has thousands of dental clinics using the product and over 300,000 teeth treated in 2024. vVARDIS' technology is already incorporated in lectures of renowned universities in the U.S. and Europe as a new standard of care for the treatment of early tooth decay.
The Water & Wastewater Equipment, Treatment and Transport (WWETT) Show Announces Inaugural Young Professionals Award Winners
INDIANAPOLIS, IN / ACCESS Newswire / February 11, 2025 / The WWETT Show, the world's largest annual tradeshow for wastewater and environmental services professionals, proudly announces the recipients of its inaugural Young Professionals Award program.
CGFNS International Reports Nurse Migration Rates to the U.S. Remained High in 2024
Uncertain outlook for 2025 as new immigration policies are implemented
Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market
Finalizing scale-up production phaseEngaging with Contract Research Organizations to complete the technical dossierClinical trials expected to complete in late 2025 or early 2026Potential classification as a Class III medical deviceProduct launch expected in the first or second quarter of 2026Further updates on progress to follow in the coming months
PUPS Pet Club Brings Premier Dog Care Services to Chicago's Vibrant Lakeshore East Community
PUPS' Seventh Chicago Location Offers Urban Pet Parents Convenient, Health Club Quality Pet Care
Boomerang Ventures Completes Series A2 Round in Wicked Technologies to Advance Incontinence Care Innovation
INDIANAPOLIS, IN / ACCESS Newswire / February 11, 2025 / Boomerang Ventures, a combination venture studio and fund, has completed a $2.1 million Series A2 funding round for Wicked Technologies, a Louisville-based company revolutionizing incontinence care with its Wicked Smart Pad™ (WSP). This investment marks Boomerang Ventures' latest commitment to investing in women-led health technology innovations that are set to revolutionize patient care.
Cellev8 Nutrition(TM) and NFL Legend Andre Reed Launch Groundbreaking Partnership at Super Bowl, Revolutionizing Cellular Health in Sports
Cellev8 Continues to breakthrough, enhance and improve the lives of athletes globally
John Muir Health Announces the Full Enterprise Rollout of Ambience Healthcare's AI Platform
Ambience's fully Epic-integrated AI technology reduces burnout and boosts patient face time